The US Patent and Trademark Office has awarded a specialist pharmaceutical company a patent for a cannabidiol treatment of Fragile X Syndrome – a genetic condition. Other items include news from Australia, Latin America, the EU and the US
Written by CannIntelligence || 18th November 2019 || News analysis | Companies | Marketing and retailing | Europe